May Conference Roundup: AXS24, Digestive Disease Week

News
Article

Take a look back at the conference coverage you may have missed this month.

Digestive Disease Week

Digestive Disease Week 2024 was held May 18 to 21 in Washington, DC.

Examining Immune Response of Hepatitis B Vaccines in Patients With HCV

The significant association between immune response and administration of a standard or multi-dose hepatitis B vaccine was not noted in those with hepatitis C virus, according to researchers.

Semaglutide Reduces Weight, Truncal Fat In Patients With MASLD

Semaglutide can help patients with metabolic dysfunction-associated steatotic liver disease (MASLD) lose weight and truncal fat while preserving skeletal muscle over the course of a year.

image credit: Anton Gvozdikov - stock.adobe.com

image credit: Anton Gvozdikov - stock.adobe.com

AXS24 Asembia Specialty Pharmacy Summit

The 2024 Asembia Specialty Pharmacy Summit was held April 30 to May 2 in Las Vegas, NV.

Q&A: Biosimilar Access, Pricing in the Spotlight

Lakesha Farmer, Senior Director, Strategic Accounts, ION Oncology Practice Network at Cencora, sat down with Drug Topics to discuss the biosimilar adoption, access, and pricing.

Q&A: Navigating the Exponential Growth of Specialty Drugs

Natalie Bedford, Senior Vice President, US Pharmaceutical Distribution Services at McKesson, sat down with Drug Topics to discuss the growth of the specialty drug market and the ways McKesson is helping manufacturing partners navigate regulatory changes.

Asembia: Pharmacists Have a Role in Health Care System Sustainability

Fran Gregory, Vice President of Emerging Therapies at Cardinal Health, sat down with Drug Topics to discuss the role of pharmacists in improving biosimilar uptake and advocating for health system sustainability.

Q&A: Understanding Future Impacts of the IRA

Corey Ford, Vice President of Reimbursement and Policy Insights at Cencora, sat down with Drug Topics to discuss the evolution of the Inflation Reduction Act and what stakeholders—from biopharma companies to payers—can expect in 2025 and beyond.

Don’t miss a minute of our conference coverage: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.